Activation of the AKT/mTOR cascade and alterations of glucose and lipid metabolism in CCF and HCC of humans and rats are accompanied by the upregulation of carbohydrate responsive element binding protein (chREBP) transcription factor [20, 23]. Here, MLXIPL is linked to hepatocellular carcinoma.